CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 26 filers reported holding CANDEL THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | – | 271 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 1,935,215 | $2,612,540 | 1.49% |
| Sands Capital Ventures, LLC | 811,737 | $1,095,845 | 0.27% |
| Empirical Asset Management, LLC | 12,000 | $16,200 | 0.02% |
| Baystate Wealth Management LLC | 105,854 | $142,903 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,700 | $181,799 | 0.01% |
| FRANKLIN RESOURCES INC | 1,125,000 | $1,541,250 | 0.00% |
| OneDigital Investment Advisors LLC | 25,428 | $34,328 | 0.00% |
| Ergoteles LLC | 11,416 | $15,640 | 0.00% |
| WELLS FARGO & COMPANY/MN | 100 | $135 | 0.00% |
| NORTHERN TRUST CORP | 19,617 | $26,483 | 0.00% |